25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Cell Source Inc
Buy, Hold or Sell?

Let's analyze Cell Source Inc together

I guess you are interested in Cell Source Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Cell Source Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Cell Source Inc

I send you an email if I find something interesting about Cell Source Inc.

1. Quick Overview

1.1. Quick analysis of Cell Source Inc (30 sec.)










1.2. What can you expect buying and holding a share of Cell Source Inc? (30 sec.)

How much money do you get?

How much money do you get?
$29,295.29
When do you have the money?
1 year
How often do you get paid?
25.0%

What is your share worth?

Current worth
$-0.41
Expected worth in 1 year
$-0.47
How sure are you?
32.5%

+ What do you gain per year?

Total Gains per Share
$29,295.24
Return On Investment
4,821,467.6%

For what price can you sell your share?

Current Price per Share
$0.61
Expected price per share
$0.4 - $1
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Cell Source Inc (5 min.)




Live pricePrice per Share (EOD)
$0.61
Intrinsic Value Per Share
$-0.43 - $-0.08
Total Value Per Share
$-0.84 - $-0.50

2.2. Growth of Cell Source Inc (5 min.)




Is Cell Source Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$17.3m-$12.9m-$3.1m-19.8%

How much money is Cell Source Inc making?

Current yearPrevious yearGrowGrow %
Making money-$1.2m-$1.4m$182.9k14.9%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Cell Source Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#906 / 954

Most Revenue
#925 / 954

Most Profit
#254 / 954

Most Efficient
#298 / 954
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Cell Source Inc?

Welcome investor! Cell Source Inc's management wants to use your money to grow the business. In return you get a share of Cell Source Inc.

First you should know what it really means to hold a share of Cell Source Inc. And how you can make/lose money.

Speculation

The Price per Share of Cell Source Inc is $0.6076. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Cell Source Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Cell Source Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.41. Based on the TTM, the Book Value Change Per Share is $-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.02 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $7,323.82 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Cell Source Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.04-5.8%-0.03-4.8%-0.04-6.6%-0.03-5.7%-0.03-4.3%
Usd Book Value Change Per Share-0.04-6.7%-0.01-2.3%-0.02-4.1%-0.01-2.4%-0.01-1.5%
Usd Dividend Per Share0.011.3%7,323.821,205,369.2%0.010.9%2,511.15413,290.0%1,524.57250,916.9%
Usd Total Gains Per Share-0.03-5.4%7,323.811,205,366.9%-0.02-3.2%2,511.14413,287.6%1,524.56250,915.4%
Usd Price Per Share0.00-0.34-0.32-0.81-0.73-
Price to Earnings Ratio-0.01--3.10--1.93--6.10--7.67-
Price-to-Total Gains Ratio-0.02-3.52--6.18--22.43--28.53-
Price to Book Ratio0.00--0.91--1.02--3.95--4.79-
Price-to-Total Gains Ratio-0.02-3.52--6.18--22.43--28.53-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.6076
Number of shares1645
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share7,323.822,511.15
Usd Book Value Change Per Share-0.01-0.01
Usd Total Gains Per Share7,323.812,511.14
Gains per Quarter (1645 shares)12,047,666.194,130,817.50
Gains per Year (1645 shares)48,190,664.7616,523,269.98
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
148190758-934819065516523365-9516523260
296381516-1869638132033046731-19133046530
3144572274-27914457198549570096-28649569800
4192763031-37219276265066093462-38266093070
5240953789-46624095331582616827-47782616340
6289144547-55928914398099140192-57399139610
7337335305-652337334645115663558-668115662880
8385526063-745385525310132186923-763132186150
9433716821-838433715975148710289-859148709420
10481907579-931481906640165233654-954165232690

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%1.039.00.02.5%1.043.00.02.3%
Book Value Change Per Share1.02.01.025.0%3.07.02.025.0%4.013.03.020.0%10.025.05.025.0%12.027.05.027.3%
Dividend per Share3.00.01.075.0%5.00.07.041.7%7.00.013.035.0%10.00.030.025.0%10.00.034.022.7%
Total Gains per Share2.02.00.050.0%4.07.01.033.3%6.013.01.030.0%13.025.02.032.5%15.027.02.034.1%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Cell Source Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.041-0.014-65%-0.025-39%-0.015-64%-0.009-77%
Book Value Per Share---0.413-0.385-7%-0.309-25%-0.256-38%-0.191-54%
Current Ratio--0.0240.016+51%0.025-1%0.027-10%0.037-34%
Debt To Asset Ratio--41.30067.206-39%43.343-5%56.205-27%45.494-9%
Debt To Equity Ratio----0%-0%-0%-0%
Dividend Per Share--0.0087323.823-100%0.005+46%2511.150-100%1524.571-100%
Eps---0.035-0.029-17%-0.040+13%-0.035-2%-0.026-27%
Free Cash Flow Per Share---0.027-0.017-37%-0.017-38%-0.016-40%-0.014-47%
Free Cash Flow To Equity Per Share--0.0020.001+228%0.002+38%0.000+1244%0.000+121%
Gross Profit Margin--1.0001.0000%1.0000%101975.314-100%50988.169-100%
Intrinsic Value_10Y_max---0.084--------
Intrinsic Value_10Y_min---0.427--------
Intrinsic Value_1Y_max---0.050--------
Intrinsic Value_1Y_min---0.057--------
Intrinsic Value_3Y_max---0.118--------
Intrinsic Value_3Y_min---0.160--------
Intrinsic Value_5Y_max---0.148--------
Intrinsic Value_5Y_min---0.250--------
Market Cap25483594.640+100%33553.12014383803.130-100%13344704.945-100%33984067.885-100%30802393.281-100%
Net Profit Margin----0%-0%-0%0.0000%
Operating Margin----0%-0%-0%0.0000%
Operating Ratio----0%-0%-0%0.000-100%
Pb Ratio-1.471-75850%-0.002-0.911+46913%-1.018+52434%-3.952+203903%-4.794+247348%
Pe Ratio-4.279-75850%-0.006-3.102+54951%-1.929+34140%-6.097+108116%-7.673+136077%
Price Per Share0.608+100%0.0010.343-100%0.318-100%0.810-100%0.734-100%
Price To Free Cash Flow Ratio-5.673-75850%-0.007-8.418+112592%-6.644+88848%-14.105+188729%-16.368+219030%
Price To Total Gains Ratio-18.449-75850%-0.0243.521-101%-6.185+25362%-22.425+92219%-28.527+117337%
Quick Ratio--0.0050.002+206%0.004+43%0.008-39%0.009-41%
Return On Assets---3.464-4.903+42%-4.725+36%-6.770+95%-5.847+69%
Return On Equity----0%-0%-0%-0%
Total Gains Per Share---0.0337323.809-100%-0.020-41%2511.135-100%1524.562-100%
Usd Book Value---17319501.000-16143183.500-7%-12949122.000-25%-10717921.550-38%-8001825.950-54%
Usd Book Value Change Per Share---0.041-0.014-65%-0.025-39%-0.015-64%-0.009-77%
Usd Book Value Per Share---0.413-0.385-7%-0.309-25%-0.256-38%-0.191-54%
Usd Dividend Per Share--0.0087323.823-100%0.005+46%2511.150-100%1524.571-100%
Usd Eps---0.035-0.029-17%-0.040+13%-0.035-2%-0.026-27%
Usd Free Cash Flow---1122970.000-711879.750-37%-696083.250-38%-674268.500-40%-594817.425-47%
Usd Free Cash Flow Per Share---0.027-0.017-37%-0.017-38%-0.016-40%-0.014-47%
Usd Free Cash Flow To Equity Per Share--0.0020.001+228%0.002+38%0.000+1244%0.000+121%
Usd Market Cap25483594.640+100%33553.12014383803.130-100%13344704.945-100%33984067.885-100%30802393.281-100%
Usd Price Per Share0.608+100%0.0010.343-100%0.318-100%0.810-100%0.734-100%
Usd Profit---1488788.000-1231683.000-17%-1414672.000-5%-1227599.350-18%-946992.800-36%
Usd Revenue----0%-0%-0%931575000.000-100%
Usd Total Gains Per Share---0.0337323.809-100%-0.020-41%2511.135-100%1524.562-100%
 EOD+6 -2MRQTTM+7 -22YOY+11 -185Y+6 -2410Y+7 -25

3.3 Fundamental Score

Let's check the fundamental score of Cell Source Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-4.279
Price to Book Ratio (EOD)Between0-1-1.471
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.005
Current Ratio (MRQ)Greater than10.024
Debt to Asset Ratio (MRQ)Less than141.300
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-3.464
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of Cell Source Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.442
Ma 20Greater thanMa 500.589
Ma 50Greater thanMa 1000.429
Ma 100Greater thanMa 2000.334
OpenGreater thanClose0.449
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About Cell Source Inc

Cell Source, Inc., a biotechnology company, engages in developing cell therapy treatments based on the management of immune tolerance. Its lead product is the Veto Cell immune system management technology, which is an immune tolerance biotechnology that enables the selective blocking of immune responses. The company's Veto Cell technology is used in various applications, including treatment of lymphoma, leukemia, and multiple myeloma through facilitation of the stem cell transplantation acceptance, as well as treatment of end stage kidney disease; other non-malignant organ diseases through organ transplantation; and various cancers and non-malignant diseases. Cell Source, Inc. is headquartered in New York, New York.

Fundamental data was last updated by Penke on 2024-11-17 02:38:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Cell Source Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Cell Source Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Cell Source Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y0.0%+0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--120.2%+120.2%
TTM--210.7%+210.7%
YOY--219.8%+219.8%
5Y--348.0%+348.0%
10Y0.0%-473.2%+473.2%
4.3.1.2. Return on Assets

Shows how efficient Cell Source Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Cell Source Inc to the Biotechnology industry mean.
  • -346.4% Return on Assets means that Cell Source Inc generated $-3.46 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Cell Source Inc:

  • The MRQ is -346.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -490.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-346.4%TTM-490.3%+143.9%
TTM-490.3%YOY-472.5%-17.7%
TTM-490.3%5Y-677.0%+186.7%
5Y-677.0%10Y-584.7%-92.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-346.4%-11.0%-335.4%
TTM-490.3%-11.7%-478.6%
YOY-472.5%-11.3%-461.2%
5Y-677.0%-12.6%-664.4%
10Y-584.7%-14.3%-570.4%
4.3.1.3. Return on Equity

Shows how efficient Cell Source Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Cell Source Inc to the Biotechnology industry mean.
  • 0.0% Return on Equity means Cell Source Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Cell Source Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--14.1%+14.1%
TTM--15.8%+15.8%
YOY--13.8%+13.8%
5Y--18.5%+18.5%
10Y--19.2%+19.2%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Cell Source Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Cell Source Inc is operating .

  • Measures how much profit Cell Source Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Cell Source Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Cell Source Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y0.0%+0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--267.8%+267.8%
TTM--313.2%+313.2%
YOY--224.0%+224.0%
5Y--385.5%+385.5%
10Y0.0%-498.7%+498.7%
4.3.2.2. Operating Ratio

Measures how efficient Cell Source Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Cell Source Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y0.0000.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.631-2.631
TTM-3.412-3.412
YOY-3.299-3.299
5Y-4.788-4.788
10Y0.0006.538-6.538
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Cell Source Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Cell Source Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.02 means the company has $0.02 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Cell Source Inc:

  • The MRQ is 0.024. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.016. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.024TTM0.016+0.008
TTM0.016YOY0.025-0.008
TTM0.0165Y0.027-0.011
5Y0.02710Y0.037-0.010
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0243.688-3.664
TTM0.0163.875-3.859
YOY0.0254.695-4.670
5Y0.0275.959-5.932
10Y0.0376.274-6.237
4.4.3.2. Quick Ratio

Measures if Cell Source Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Cell Source Inc to the Biotechnology industry mean.
  • A Quick Ratio of 0.01 means the company can pay off $0.01 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Cell Source Inc:

  • The MRQ is 0.005. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.002. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.005TTM0.002+0.003
TTM0.002YOY0.004-0.002
TTM0.0025Y0.008-0.007
5Y0.00810Y0.0090.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0053.117-3.112
TTM0.0023.444-3.442
YOY0.0044.498-4.494
5Y0.0085.922-5.914
10Y0.0096.414-6.405
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Cell Source Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Cell Source Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Cell Source Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 41.30 means that Cell Source Inc assets are financed with 4,130.0% credit (debt) and the remaining percentage (100% - 4,130.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Cell Source Inc:

  • The MRQ is 41.300. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 67.206. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ41.300TTM67.206-25.906
TTM67.206YOY43.343+23.863
TTM67.2065Y56.205+11.000
5Y56.20510Y45.494+10.711
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ41.3000.354+40.946
TTM67.2060.350+66.856
YOY43.3430.310+43.033
5Y56.2050.366+55.839
10Y45.4940.382+45.112
4.5.4.2. Debt to Equity Ratio

Measures if Cell Source Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Cell Source Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Cell Source Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.393-0.393
TTM-0.436-0.436
YOY-0.378-0.378
5Y-0.451-0.451
10Y-0.493-0.493
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Cell Source Inc generates.

  • Above 15 is considered overpriced but always compare Cell Source Inc to the Biotechnology industry mean.
  • A PE ratio of -0.01 means the investor is paying $-0.01 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Cell Source Inc:

  • The EOD is -4.279. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.006. Based on the earnings, the company is expensive. -2
  • The TTM is -3.102. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.279MRQ-0.006-4.274
MRQ-0.006TTM-3.102+3.096
TTM-3.102YOY-1.929-1.173
TTM-3.1025Y-6.097+2.995
5Y-6.09710Y-7.673+1.575
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-4.279-2.169-2.110
MRQ-0.006-2.453+2.447
TTM-3.102-3.147+0.045
YOY-1.929-3.335+1.406
5Y-6.097-6.032-0.065
10Y-7.673-6.597-1.076
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Cell Source Inc:

  • The EOD is -5.673. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.007. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -8.418. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-5.673MRQ-0.007-5.666
MRQ-0.007TTM-8.418+8.410
TTM-8.418YOY-6.644-1.774
TTM-8.4185Y-14.105+5.687
5Y-14.10510Y-16.368+2.263
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-5.673-3.020-2.653
MRQ-0.007-3.395+3.388
TTM-8.418-3.650-4.768
YOY-6.644-4.541-2.103
5Y-14.105-8.375-5.730
10Y-16.368-9.277-7.091
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Cell Source Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.00 means the investor is paying $0.00 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Cell Source Inc:

  • The EOD is -1.471. Based on the equity, the company is expensive. -2
  • The MRQ is -0.002. Based on the equity, the company is expensive. -2
  • The TTM is -0.911. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.471MRQ-0.002-1.469
MRQ-0.002TTM-0.911+0.909
TTM-0.911YOY-1.018+0.107
TTM-0.9115Y-3.952+3.041
5Y-3.95210Y-4.794+0.842
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.4711.860-3.331
MRQ-0.0022.035-2.037
TTM-0.9112.339-3.250
YOY-1.0182.391-3.409
5Y-3.9523.666-7.618
10Y-4.7944.360-9.154
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets430
Total Liabilities17,749
Total Stockholder Equity-17,320
 As reported
Total Liabilities 17,749
Total Stockholder Equity+ -17,320
Total Assets = 430

Assets

Total Assets430
Total Current Assets430
Long-term Assets0
Total Current Assets
Cash And Cash Equivalents 91
Other Current Assets 339
Total Current Assets  (as reported)430
Total Current Assets  (calculated)430
+/-0
Long-term Assets
Long-term Assets  (as reported)0
Long-term Assets  (calculated)0
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities17,749
Long-term Liabilities0
Total Stockholder Equity-17,320
Total Current Liabilities
Short-term Debt 10,007
Short Long Term Debt 9,664
Accounts payable 1,752
Other Current Liabilities 5,890
Total Current Liabilities  (as reported)17,749
Total Current Liabilities  (calculated)27,313
+/- 9,564
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock42
Retained Earnings -44,432
Other Stockholders Equity 27,069
Total Stockholder Equity (as reported)-17,320
Total Stockholder Equity (calculated)-17,320
+/- 1
Other
Capital Stock44
Cash and Short Term Investments 91
Common Stock Shares Outstanding 41,019
Current Deferred Revenue100
Liabilities and Stockholders Equity 430
Net Debt 9,917
Net Invested Capital -7,658
Net Working Capital -17,320
Short Long Term Debt Total 10,007



6.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-09-30
> Total Assets 
0
0
0
12
19
2
1,086
273
123
407
319
312
368
368
249
282
211
67
228
150
532
411
67
411
66
66
80
77
115
132
82
210
452
452
309
861
314
314
45
277
410
232
362
248
195
195
430
43019519524836223241027745314314861309452452210821321157780666641167411532150228672112822493683683123194071232731,08621912000
   > Total Current Assets 
0
0
0
12
19
2
1,084
271
121
405
318
290
338
338
248
262
211
66
228
150
532
411
66
411
66
66
80
77
115
132
82
210
452
452
305
861
314
314
45
277
410
232
362
248
195
195
430
43019519524836223241027745314314861305452452210821321157780666641166411532150228662112622483383382903184051212711,08421912000
       Cash And Cash Equivalents 
0
0
0
12
19
2
889
104
19
276
105
6
7
7
4
2
4
18
18
40
371
211
18
211
19
19
28
9
28
17
1
55
245
245
82
599
93
93
3
132
223
133
22
3
22
22
91
912222322133223132393935998224524555117289281919211182113714018184247761052761910488921912000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000000000000000
       Other Current Assets 
0
0
0
0
0
0
60
74
26
79
69
101
259
135
136
146
70
14
53
26
36
28
14
28
8
8
29
28
30
29
35
20
207
30
8
17
17
17
16
24
23
15
16
3
12
173
339
33917312316152324161717178302072035293028298828142836265314701461361352591016979267460000000
   > Long-term Assets 
0
0
0
0
0
0
3
2
2
2
2
21
0
30
1
21
0
0
0
0
0
0
0
0
0
46,858,000
0
0
86,875,000
0
0
0
0
207,220,000
4
0
0
0
0
0
0
0
0
0
0
172,968,000
0
0172,968,00000000000004207,220,000000086,875,0000046,858,0000000000002113002122223000000
       Property Plant Equipment 
0
0
0
0
0
0
3
2
2
2
2
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000001111122223000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
28
0
0
20
0
0
0
0
0
0
0
200
0
-46,858,000
52
69
-86,875,000
115
81
156
0
-207,220,000
0
0
0
0
0
277
0
0
99
246
0
-172,968,000
339
339-172,968,0000246990027700000-207,220,000015681115-86,875,0006952-46,858,00002000000000200028000000000000
> Total Liabilities 
0
0
0
4
7
3
2,763
2,492
3,907
4,748
5,231
5,856
6,126
6,126
7,481
8,094
6,454
5,610
5,484
5,714
5,089
5,738
5,610
5,738
4,986
4,986
5,233
5,992
5,857
6,390
6,610
7,229
8,400
8,400
10,335
11,049
10,140
10,140
10,811
10,274
13,044
14,452
15,308
16,279
15,807
15,807
17,749
17,74915,80715,80716,27915,30814,45213,04410,27410,81110,14010,14011,04910,3358,4008,4007,2296,6106,3905,8575,9925,2334,9864,9865,7385,6105,7385,0895,7145,4845,6106,4548,0947,4816,1266,1265,8565,2314,7483,9072,4922,763374000
   > Total Current Liabilities 
0
0
0
4
7
3
2,763
2,492
3,907
4,748
5,231
5,856
6,050
6,050
7,317
8,094
6,454
5,610
5,484
5,714
5,089
5,738
5,610
5,738
4,986
4,986
5,233
5,992
5,712
6,390
6,610
7,229
8,400
8,400
10,335
11,049
10,140
10,140
10,811
10,274
13,044
14,452
15,308
16,279
15,807
15,807
17,749
17,74915,80715,80716,27915,30814,45213,04410,27410,81110,14010,14011,04910,3358,4008,4007,2296,6106,3905,7125,9925,2334,9864,9865,7385,6105,7385,0895,7145,4845,6106,4548,0947,3176,0506,0505,8565,2314,7483,9072,4922,763374000
       Short-term Debt 
0
0
0
0
0
0
0
0
100
425
664
759
1,716
1,194
2,415
2,879
3,088
2,393
2,424
2,424
801
829
2,393
2,928
835
2,673
1,983
2,093
2,453
3,058
3,433
3,880
4,656
4,806
6,874
7,027
0
6,469
0
6,139
0
0
9,456
9,474
0
9,254
10,007
10,0079,25409,4749,456006,13906,46907,0276,8744,8064,6563,8803,4333,0582,4532,0931,9832,6738352,9282,3938298012,4242,4242,3933,0882,8792,4151,1941,71675966442510000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
1,716
2,206
2,555
3,079
0
2,393
2,424
2,424
801
829
835
835
835
1,983
1,983
2,093
2,453
3,058
3,433
3,880
4,806
5,796
6,874
7,027
6,469
6,139
6,209
7,185
7,904
8,566
9,456
9,474
9,254
9,300
9,664
9,6649,3009,2549,4749,4568,5667,9047,1856,2096,1396,4697,0276,8745,7964,8063,8803,4333,0582,4532,0931,9831,9838358358358298012,4242,4242,39303,0792,5552,2061,716000000000000
       Accounts payable 
0
0
0
0
0
0
0
0
0
638
450
450
7
450
200
200
219
233
256
254
202
202
233
202
278
278
294
449
135
313
446
376
2,924
193
340
285
223
223
382
333
680
1,187
928
1,581
1,467
1,467
1,752
1,7521,4671,4671,5819281,1876803333822232232853401932,9243764463131354492942782782022332022022542562332192002004507450450638000000000
       Other Current Liabilities 
0
0
0
4
7
3
2,763
2,492
3,807
2,462
2,472
2,773
3,280
-449,995,595
4,502
4,814
1,175
1,317
1,044
1,179
837
858
1,071
542
314
-99,997,965
2,857
3,350
-99,996,877
2,919
2,631
2,872
819
-99,996,599
3,022
3,637
302
-99,996,552
275
3,702
240
538
322
5,124
81
5,060
5,890
5,8905,060815,1243225382403,702275-99,996,5523023,6373,022-99,996,5998192,8722,6312,919-99,996,8773,3502,857-99,997,9653145421,0718588371,1791,0441,3171,1754,8144,502-449,995,5953,2802,7732,4722,4623,8072,4922,763374000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
100
1,063
1,114
1,209
0
76
164
3,079
3,307
0
0
0
0
0
2,625
3,130
0
2,951
2,277
2,542
145
3,371
3,879
4,256
0
4,999
7,214
7,312
0
6,692
0
6,472
0
0
0
0
0
0
0
00000006,47206,69207,3127,2144,99904,2563,8793,3711452,5422,2772,95103,1302,625000003,3073,0791647601,2091,1141,06310000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
4
18
15
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000015184000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
28
0
0
20
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000200028000000000000
> Total Stockholder Equity
0
0
0
8
11
-1
-1,677
-2,219
-3,784
-4,340
-4,911
-5,545
-5,758
-5,758
-7,232
-7,811
-6,243
-5,544
-5,256
-5,565
-4,558
-5,328
-5,544
-5,327
-4,921
-4,920
-5,154
-5,915
-5,742
-6,258
-6,528
-7,018
-7,947
-7,947
-10,027
-10,188
-9,826
-9,826
-10,767
-9,997
-12,634
-14,220
-14,946
-16,030
-15,612
-15,612
-17,320
-17,320-15,612-15,612-16,030-14,946-14,220-12,634-9,997-10,767-9,826-9,826-10,188-10,027-7,947-7,947-7,018-6,528-6,258-5,742-5,915-5,154-4,920-4,921-5,327-5,544-5,328-4,558-5,565-5,256-5,544-6,243-7,811-7,232-5,758-5,758-5,545-4,911-4,340-3,784-2,219-1,677-1118000
   Common Stock
0
0
0
6
6
8
23
24
24
24
24
24
24
24
24
24
25
25
25
25
25
25
25
25
26
26
26
26
27
27
30
30
33
33
33
34
34
34
35
34
36
37
38
38
0
40
42
424003838373634353434343333333030272726262626252525252525252524242424242424242423866000
   Retained Earnings Total Equity000000000000-28,544-25,706-25,70600000000000000000000000000000000
   Accumulated Other Comprehensive Income -1-400-1-1000000-2-1-10-1-1-1-1-1-1-10-100000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
17,725
17,725
18,482
0
0
0
0
0
0
0
0
0
0
0
0
00000000000018,48217,72517,72500000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
17
36
35
4,047
4,191
4,191
4,191
4,191
4,231
0
4,720
4,768
4,991
5,203
0
0
0
0
0
7,045
9,913
0
11,724
13,902
14,629
15,377
15,674
16,567
17,383
0
17,726
18,484
20,122
0
21,316
0
22,438
0
0
24,294
24,548
0
26,054
27,069
27,06926,054024,54824,2940022,438021,316020,12218,48417,726017,38316,56715,67415,37714,62913,90211,72409,9137,045000005,2034,9914,7684,72004,2314,1914,1914,1914,1914,047353617000



6.3. Balance Sheets

Currency in USD. All numbers in thousands.




6.4. Cash Flows

Currency in USD. All numbers in thousands.




6.5. Income Statements

Currency in USD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-4,175
Operating Income-4,175-4,175
 
Operating Expense (+$)
Research Development1,996
Selling General Administrative2,179
Selling And Marketing Expenses2,604,748,395
Operating Expense4,1752,604,752,571
 
Net Interest Income (+$)
Interest Income0
Interest Expense-992
Other Finance Cost-269
Net Interest Income-1,261
 
Pretax Income (+$)
Operating Income-4,175
Net Interest Income-1,261
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-5,168992,410,825
EBIT - interestExpense = -5,168
-992,419,180
-4,175
Interest Expense992
Earnings Before Interest and Taxes (EBIT)-4,175-4,175
Earnings Before Interest and Taxes (EBITDA)-4,175
 
After tax Income (+$)
Income Before Tax-5,168
Tax Provision-0
Net Income From Continuing Ops-5,609-5,168
Net Income-5,168
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses4,175
Total Other Income/Expenses Net-992,415,0001,261
 

Technical Analysis of Cell Source Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Cell Source Inc. The general trend of Cell Source Inc is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Cell Source Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Cell Source Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.75 < 0.75 < 1.

The bearish price targets are: 0.48 > 0.48 > 0.4.

Tweet this
Cell Source Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Cell Source Inc. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Cell Source Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Cell Source Inc. The current macd is 0.04326055.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Cell Source Inc price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Cell Source Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Cell Source Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Cell Source Inc Daily Moving Average Convergence/Divergence (MACD) ChartCell Source Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Cell Source Inc. The current adx is 32.05.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Cell Source Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Cell Source Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Cell Source Inc. The current sar is 0.15022.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Cell Source Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Cell Source Inc. The current rsi is 54.44. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Cell Source Inc Daily Relative Strength Index (RSI) ChartCell Source Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Cell Source Inc. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Cell Source Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Cell Source Inc Daily Stochastic Oscillator ChartCell Source Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Cell Source Inc. The current cci is -25.57345906.

Cell Source Inc Daily Commodity Channel Index (CCI) ChartCell Source Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Cell Source Inc. The current cmo is 7.38547865.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Cell Source Inc Daily Chande Momentum Oscillator (CMO) ChartCell Source Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Cell Source Inc. The current willr is -16.47058824.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Cell Source Inc Daily Williams %R ChartCell Source Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Cell Source Inc.

Cell Source Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Cell Source Inc. The current atr is 0.12583361.

Cell Source Inc Daily Average True Range (ATR) ChartCell Source Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Cell Source Inc. The current obv is 226,616.

Cell Source Inc Daily On-Balance Volume (OBV) ChartCell Source Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Cell Source Inc. The current mfi is 9.29261471.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Cell Source Inc Daily Money Flow Index (MFI) ChartCell Source Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Cell Source Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-31ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-13RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-08-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-19STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-08-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-08-23STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-08-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-05STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-23CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-07MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-10WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-14STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-17STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-23WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-25RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-10-28STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-29RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-30STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-11-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-15WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside

6.3. Candlestick Patterns

Cell Source Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Cell Source Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.442
Ma 20Greater thanMa 500.589
Ma 50Greater thanMa 1000.429
Ma 100Greater thanMa 2000.334
OpenGreater thanClose0.449
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Cell Source Inc with someone you think should read this too:
  • Are you bullish or bearish on Cell Source Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Cell Source Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Cell Source Inc

I send you an email if I find something interesting about Cell Source Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Cell Source Inc.

Receive notifications about Cell Source Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.